VITREX MEDICAL A/S: Financial statements 2022
CVR: 14728732
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
VITREX MEDICAL A/S (CVR 14728732) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 26,582,922 and a net result of DKK 4,052,982 compared with DKK 5,501,882 the year before. That is a decrease of 7.1% compared with the year before. Equity in the 2022 report amounted to DKK 33,033,344. The solvency ratio was 50.3%. The company had 73 employees in the financial year.
- Gross Profit
- DKK 26,582,922
- Profit/Loss
- DKK 4,052,982
- Equity
- DKK 33,033,344
- Total Assets
- DKK 65,731,326
- Employees
- 73
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 26.6M | 4.1M | 33M | 73 |
| 2021 | - | 28.6M | 5.5M | 32M | 68 |
| 2020 | - | 25.9M | 7.6M | 31.5M | 64 |
| 2019 | - | 21.6M | 4.1M | 24.9M | 60 |
| 2018 | - | 25.1M | 8.7M | 25.8M | - |
Official annual report
Keep an eye on VITREX MEDICAL A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
VITREX MEDICAL A/S has published its annual report for 2021. Gross profit came to DKK 28,623,030, and the net result was DKK 5,501,882.
About VITREX MEDICAL A/S
VITREX MEDICAL A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 1990. The company is registered under the industry Fremstilling og bearbejdning af andet glas, herunder teknisk glas. The company was previously named MODULOHM A/S and A/S PSE NR. 4106. The management consists of Anders Folkmar Pedersen. The board consists of Michal Staron (chair), Marcin Sieczek and Vagn Andersen. The company is owned by CHIRANA T.Injecta, a. s.. The company has 60 employees (2026). In 2025, the company reported a gross profit of DKK 34,669,165 and a net result of DKK 6,179,533 compared with DKK 1,819,121 the year before. Equity in the 2025 report amounted to DKK 42,246,689.
